A Chinese woman who reportedly looked pregnant with triplets had a 77lb (35kg) tumour removed from her ovary. Ms Huang, whose first name is not known, had been struggling to breathe because of the ...

IMPACT Therapeutics has received the China National Medical Products Administration (NMPA) marketing authorisation for Senaparib capsules to treat ovarian cancer. The authorisation allows the ...

Moderate and severe ovarian hyperstimulation syndrome (OHSS) developed in 1.14% of Chinese women of reproductive age between 2013 and 2017. Moreover, women under 35 years of age receiving assisted ...

Epidemiological studies have shown that HRR variants are linked to inherited ovarian diseases, providing valuable guidance for early prevention and tailored treatment in the Chinese population.